Sodium Carboxymethyl Cellulose (CMC)
What is sodium carboxymethyl cellulose?
Sodium carboxymethyl cellulose (CMC, NaCMC, sodium CMC), also known as carmellose sodium, is a water-soluble, anionic cellulose ether widely used as a pharmaceutical excipient. It is produced by chemically modifying purified cellulose with carboxymethyl groups, followed by neutralization to the sodium salt.
The introduction of negatively charged carboxymethyl groups disrupts the extensive hydrogen bonding between cellulose chains, making the polymer readily soluble in water and capable of forming highly viscous aqueous solutions.
Unlike cellulose itself, which is insoluble in water, sodium carmellose sodium hydrates and forms clear or slightly opalescent viscous solutions depending on the molecular weight, degree of substitution and concentration.
The functionality of CMC is determined by several physicochemical characteristics, including molecular weight, degree of substitution, substitution distribution, particle size and purity.
Sodium carboxymethyl cellulose should not be confused with hydroxypropyl cellulose (HPC) or hypromellose (HPMC). Although all three belong to the family of cellulose ethers, they differ considerably in chemical structure, ionic character and pharmaceutical functionality.
Figure 1 Structural formula of Sodium carboxymethyl cellulose (CMC). The substituent R represents either -H or -CH2COONa
Sodium Carboxymethyl Cellulose Characterization Services
Excipia offers fast and flexible hands-on services to reveal and compare hidden CMC properties like:
The presence of potential reactive impurities or functional groups, degradation products and related substances, just like molecular weight distributions, degree of substitution, substituent distribution, monomer ratio and many other featured characteristics.
In addition, we can help users of sodium CMC to pick the most appropriate CMC manufacturer, select the most suitable sodium carboxymethyl cellulosegrade for your finished dosage form, or define customized CMC specifications to control product performance, quality and safety.
Pharmaceutical Applications of Sodium carboxymethyl cellulose
One of the most important structural characteristics of sodium carboxymethyl cellulose (CMC) is its degree of substitution (DS). The degree of substitution represents the average number of hydroxyl groups on each anhydroglucose unit that have been replaced by carboxymethyl groups. Since every glucose unit contains three hydroxyl groups, the theoretical maximum DS is 3.
Commercial pharmaceutical CMC grades commonly have a degree of substitution of approximately 0.6–1.0, although grades with higher substitution are also available. The applicable substitution range depends on the intended functionality and the relevant pharmacopoeial monograph.
The degree of substitution strongly influences the physicochemical properties of sodium carboxymethyl cellulose. At relatively low substitution, the polymer retains more of the insoluble character of native cellulose. Increasing carboxymethyl substitution generally improves aqueous dispersibility and solubility, although the observed behaviour also depends on the distribution of the substituents, molecular weight, polymer concentration, pH and ionic strength.
Average DS alone does not fully describe a CMC material. Two pharmaceutical grades may possess a similar average degree of substitution while differing in the distribution of carboxymethyl groups along the cellulose chains. These structural differences can influence viscosity, hydration rate, rheological behaviour, suspension stability and interactions with active pharmaceutical ingredients. For this reason, detailed characterization of substitution patterns can provide valuable information during formulation development, supplier qualification and reverse engineering studies.
Production of Sodium Carboxymethyl Cellulose (Sodium CMC)
Sodium carboxymethyl cellulose is manufactured from purified cellulose obtained from wood pulp or cotton linters.
The cellulose is first activated with sodium hydroxide, producing alkali cellulose. Monochloroacetic acid or sodium monochloroacetate subsequently reacts with the accessible hydroxyl groups of cellulose to introduce carboxymethyl substituents.
Following etherification, the polymer is purified to remove reaction salts and by-products before drying, milling and classification.
The simplified reaction is:
Cell–OH + ClCH₂COONa → Cell–O–CH₂COONa
The final product contains sodium carboxymethyl groups distributed along the cellulose chains.
Manufacturing conditions strongly influence the molecular architecture of the polymer and consequently its pharmaceutical performance.
Degree of Substitution
One of the most important structural characteristics of sodium carboxymethyl cellulose (CMC) is its degree of substitution (DS). The degree of substitution represents the average number of hydroxyl groups on each anhydroglucose unit that have been replaced by carboxymethyl groups. Since every glucose unit contains three hydroxyl groups, the theoretical maximum DS is 3.
Commercial pharmaceutical carmellose sodium grades commonly have a degree of substitution of approximately 0.6–1.0, although grades with higher substitution are also available. The applicable substitution range depends on the intended functionality and the relevant pharmacopoeial monograph.
The degree of substitution strongly influences the physicochemical properties of sodium carboxymethyl cellulose. At relatively low substitution, the polymer retains more of the insoluble character of native cellulose. Increasing carboxymethyl substitution generally improves aqueous dispersibility and solubility, although the observed behaviour also depends on the distribution of the substituents, molecular weight, polymer concentration, pH and ionic strength.
Average DS alone does not fully describe a CMC material. Two pharmaceutical grades may possess a similar average degree of substitution while differing in the distribution of carboxymethyl groups along the cellulose chains. These structural differences can influence viscosity, hydration rate, rheological behaviour, suspension stability and interactions with active pharmaceutical ingredients. For this reason, detailed characterization of substitution patterns can provide valuable information during formulation development, supplier qualification and reverse engineering studies.
Variability of Sodium Carboxymethyl Cellulose (Carmellose Sodium)
Like other cellulose ethers, sodium carboxymethyl cellulose exhibits natural variability arising from both the cellulose starting material and the manufacturing process. Differences in cellulose purity, molecular weight and fibre structure, together with variations in alkalisation, etherification, purification, drying and milling, can all influence the properties of the final excipient.
These manufacturing variables may affect the molecular-weight distribution, the degree and distribution of substitution, particle-size distribution and the amount of residual process-related salts or low-molecular-weight degradation products. Consequently, two CMC grades that comply with the same pharmacopoeial monograph and display similar certificate-of-analysis values may still behave differently during pharmaceutical manufacturing or product storage.
Such differences may become apparent as changes in viscosity, hydration rate, suspension stability, solution clarity, dissolution behaviour or compatibility with active pharmaceutical ingredients. When CMC performs a critical function in a formulation, characterization beyond routine compendial testing can therefore provide valuable insight into supplier differences, batch-to-batch variability and long-term product performance.
Physicochemical Properties of CMC
Sodium carboxymethyl cellulose is typically supplied as a white to slightly cream-coloured powder that readily hydrates when dispersed in water. Depending on its molecular weight, degree of substitution and concentration, it forms clear to slightly opalescent aqueous solutions with a broad range of viscosities.
Unlike non-ionic cellulose ethers such as hydroxypropyl cellulose (HPC) and hypromellose (HPMC), carmelose sodium is an anionic polymer. The negatively charged carboxymethyl groups provide the polymer with an excellent water-binding capacity and strong viscosity-building properties, making carmellose sodium particularly useful as a thickening agent, suspending agent and stabilizer in pharmaceutical formulations.
The rheological behaviour of CMC solutions depends on polymer concentration, molecular weight, degree of substitution and the presence of dissolved electrolytes. Because of its ionic character, solution viscosity may decrease in the presence of high salt concentrations or multivalent cations. These properties should therefore be considered during formulation development, analytical method development and stability studies.
CMC Molecular Weight and Viscosity
Commercial sodium carboxymethyl cellulose grades are frequently differentiated according to the viscosity of a standardized aqueous solution. Viscosity provides a convenient indication of polymer chain length and is commonly used by manufacturers to classify pharmaceutical CMC grades.
However, viscosity alone does not fully describe the molecular architecture of the polymer. Two CMC grades with similar apparent viscosities may possess different molecular-weight distributions, resulting in differences in hydration rate, shear behaviour, suspension stability, film formation and dissolution performance. These differences may ultimately influence the manufacturability and performance of the finished pharmaceutical product.
For applications in which CMC plays a critical functional role, additional characterization of the molecular-weight distribution using techniques such as size-exclusion chromatography can provide significantly more information than viscosity measurements alone. Combining viscosity data with molecular-weight characterization offers a more complete understanding of the relationship between polymer structure and formulation performance.
Carmellose Sodium Impurities and Related Substances
Minor components present in sodium carboxymethyl cellulose may originate from the cellulose starting material, the etherification process or subsequent polymer degradation. During manufacturing, purification removes most process-related materials, but small amounts of residual inorganic salts, reaction by-products or low-molecular-weight polymer fragments may remain within the limits defined by the relevant pharmacopoeial monographs.
Typical constituents that may be present include sodium chloride, sodium glycolate, residual cellulose, moisture, reducing sugars and oxidation products formed during processing or storage. Although these components generally comply with pharmacopoeial specifications, differences in their concentration may contribute to variations in pharmaceutical performance, stability or compatibility with chemically sensitive active pharmaceutical ingredients.
When investigating supplier differences, unexpected stability issues or formulation performance, characterization of impurities and related substances can provide valuable information beyond routine certificate-of-analysis testing. Such investigations may help identify subtle differences between CMC grades that are not apparent from standard pharmacopoeial quality-control tests alone.
Difference Between CMC and Carmellose Sodium
In pharmaceutical terminology the names sodium carboxymethyl cellulose and carmellose sodium describe the same excipient.
“Carmellose sodium” is the pharmacopoeial name used in several regulatory texts, whereas “sodium carboxymethyl cellulose” is widely used in scientific literature and by excipient manufacturers. Both names therefore refer to the same chemically modified cellulose polymer.
Difference Between CMC and Croscarmellose Sodium
Although chemically related, sodium carboxymethyl cellulose and croscarmellose sodium serve very different pharmaceutical functions.
CMC is a water-soluble polymer used primarily as a viscosity modifier, suspending agent and stabilizer. Croscarmellose sodium is a crosslinked, partly carboxymethylated cellulose. It is insoluble in water but rapidly absorbs water and swells, making it suitable as a tablet disintegrant.
The crosslinking fundamentally changes the behaviour of the polymer despite their similar chemical origin. Croscarmellose sodium is covered by separate USP–NF, Ph. Eur. and JP monographs.
Difference Between CMC and HPMC
Sodium CMC and HPMC are both water-soluble cellulose ethers but possess different chemical structures. CMC is an anionic polymer carrying negatively charged carboxymethyl groups. HPMC is non-ionic and contains methoxy and hydroxypropoxy substituents. These structural differences influence viscosity, electrolyte sensitivity, hydration behaviour, compatibility with active ingredients and controlled-release performance.
For detailed information regarding hypromellose, see our dedicated Hypromellose (HPMC) page.
Difference between CMC and MCC
Unlike microcrystalline cellulose (MCC), sodium carboxymethyl cellulose is chemically modified and water soluble. MCC is primarily used as a filler and dry binder, whereas CMC functions mainly as a viscosity modifier, suspending agent and stabilizer.
Pharmacopoeial Monographs for Carmellose Sodium
Sodium carboxymethyl cellulose is described in the major international pharmacopoeias.
Relevant monographs include:
- USP–NF: Carboxymethylcellulose Sodium
- European Pharmacopoeia: Carmellose Sodium
- Japanese Pharmacopoeia: Carmellose Sodium
The monographs include requirements relating to identity, composition, viscosity and purity. The applicable current edition should be consulted because individual tests and regional requirements may differ. USP–NF describes the excipient as Carboxymethylcellulose Sodium, whereas the European Pharmacopoeia and Japanese Pharmacopoeia use the name Carmellose Sodium.
Compliance with a pharmacopoeial monograph confirms minimum quality requirements but does not necessarily demonstrate functional equivalence between different manufacturers or grades.
Functional Equivalence
Two carmellose sodium grades complying with the same pharmacopoeial monograph may nevertheless perform differently in pharmaceutical formulations.
Important characteristics not fully captured by routine pharmacopoeial testing include molecular-weight distribution, substitution heterogeneity, hydration kinetics, rheology and interactions with active pharmaceutical ingredients.
For critical formulations, additional characterization may therefore be required during supplier qualification, formulation development or reverse engineering.
Although pharmacopoeial monographs define identity, purity and minimum quality requirements, they do not fully describe the Functionality-Related Characteristics (FRCs) of sodium carboxymethyl cellulose. FRCs are material attributes that influence excipient performance during pharmaceutical manufacturing and throughout the product lifecycle. For CMC, these include molecular-weight distribution, substitution heterogeneity, hydration kinetics, rheological behaviour, particle characteristics and interactions with active pharmaceutical ingredients. Characterization of these functionality-related characteristics can be essential when selecting suppliers, qualifying alternative grades or investigating formulation performance.
Carmellose Sodium Services
Excipia provides independent physicochemical characterization of sodium carboxymethyl cellulose, including evaluation of Functionality-Related Characteristics (FRCs) that extend beyond routine pharmacopoeial testing. While pharmacopoeial monographs establish minimum quality requirements, FRCs help explain differences in formulation performance between apparently equivalent grades.
Our analytical capabilities include:
- determination of CMC degree of substitution
- characterization of carboxymethyl substituent distribution
- investigation of structural heterogeneity between CMC samples
- molecular-weight and molecular-weight-distribution analysis
- comparison of intact CMC with partially or selectively degraded CMC fractions
- evaluation of hydration, dissolution and solution behaviour
- identification of potentially reactive impurities or functional groups
- investigation of reducing substances, degradation products and related substances
- identification and quantification of CMC in pharmaceutical products
- differentiation of CMC from HPMC, HPC and other cellulose-based excipients
In addition, Excipia can help users compare manufacturers and grades and establish customized CMC specifications to control product performance, quality and safety.
Excipia is an independent contract service platform focused on the physicochemical characterization of pharmaceutical excipients, both as raw materials and after incorporation into finished products.
More than 25 years of pharmaceutical formulation-development experience has shown that the limited information provided on an excipient certificate of analysis often cannot fully explain observed material or product behaviour. More detailed knowledge of the chemical composition and functional properties of an excipient can therefore be essential when addressing formulation, stability, manufacturing or dissolution challenges.
Over the past 15 years, Excipia scientists have developed specialized analytical and physicochemical methods, supported by tailored sample-preparation techniques, to characterize CMC and other pharmaceutical excipients.
Be in control of your product!
Welcome to Excipia, a service platform of Avivia, dedicated to the composition, quality and quantity of excipients in medicinal products.
Discover our unique services such as quantitative excipient analysis, identification, selection or specific formulation development support. Don’t forget to check out our case studies.
Feel free to contact us using the “Contact” button or by sending a message to Excipia@avivia.nl.
Menno Wiltink
Founder of Excipia.
